| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Common Stock | Options Exercise | $52.6K | +845 | +1.81% | $62.21 | 47.4K | Apr 8, 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | -$88.7K | -845 | -1.78% | $105.00 | 46.6K | Apr 8, 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Options Exercise | $171K | +3.16K | +6.78% | $54.19 | 49.7K | Apr 8, 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | -$331K | -3.16K | -6.35% | $105.00 | 46.6K | Apr 8, 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Options Exercise | $334K | +5.72K | +12.28% | $58.34 | 52.3K | Apr 8, 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | -$600K | -5.72K | -10.93% | $105.00 | 46.6K | Apr 8, 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Options Exercise | $305K | +4.1K | +8.81% | $74.30 | 50.7K | Apr 8, 2022 | Direct | |
| transaction | CVS | Common Stock | Sale | -$431K | -4.1K | -8.09% | $105.00 | 46.6K | Apr 8, 2022 | Direct | F1 |
| transaction | CVS | Common Stock | Sale | -$329K | -3.13K | -6.72% | $105.00 | 43.5K | Apr 8, 2022 | Direct | F1 |
| holding | CVS | Common Stock (pep) | 4.41K | Apr 8, 2022 | Direct | F2 | |||||
| holding | CVS | Common Stock (restricted) | 16.5K | Apr 8, 2022 | Direct | ||||||
| holding | CVS | ESOP Common Stock | 4.54K | Apr 8, 2022 | Direct | ||||||
| holding | CVS | Common Stock (restricted) | 2.83K | Apr 8, 2022 | Direct | F3 | |||||
| holding | CVS | Stock Unit (deferred) | 6.63K | Apr 8, 2022 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVS | Stock Option | Options Exercise | $0 | -845 | -49.97% | $0.00 | 846 | Apr 8, 2022 | Common Stock | 845 | $62.21 | Direct | F5 |
| transaction | CVS | Stock Option | Options Exercise | $0 | -3.16K | -25% | $0.00 | 9.47K | Apr 8, 2022 | Common Stock | 3.16K | $54.19 | Direct | F6 |
| transaction | CVS | Stock Option | Options Exercise | $0 | -5.72K | -16.67% | $0.00 | 28.6K | Apr 8, 2022 | Common Stock | 5.72K | $58.34 | Direct | F7 |
| transaction | CVS | Stock Option | Options Exercise | $0 | -4.1K | -12.5% | $0.00 | 28.7K | Apr 8, 2022 | Common Stock | 4.1K | $74.30 | Direct | F8 |
| holding | CVS | Stock Option | 2.94K | Apr 8, 2022 | Common Stock | 2.94K | $104.82 | Direct | F9 | |||||
| holding | CVS | Stock Option | 26.6K | Apr 8, 2022 | Common Stock | 26.6K | $75.24 | Direct | F10 | |||||
| holding | CVS | Phantom Stock Credits | 11.3K | Apr 8, 2022 | Common Stock | 11.3K | $1.00 | Direct | F11, F12 | |||||
| holding | CVS | Stock Option | 41.6K | Apr 8, 2022 | Common Stock | 41.6K | $101.09 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
| F2 | Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023. |
| F3 | Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions on the 2018 grant lapse in three equal installments commencing on 02/26/2022; restrictions on the 2020 grant lapse in two equal installments commencing on 2/28/22. |
| F4 | Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer. |
| F5 | Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised. |
| F6 | Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised. |
| F7 | Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised. |
| F8 | Option becomes exercisable in three equal installments commencing 04/01/2022. |
| F9 | Option becomes exercisable in four equal installments commencing 04/01/2017. |
| F10 | Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023. |
| F11 | Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
| F12 | Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
| F13 | Option becomes exercisable in four equal installments, commencing 4/1/2023. |